• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构HIV-1整合酶抑制剂通过直接介导亚基间相互作用促进异常蛋白质多聚化:结构和热力学建模研究

Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.

作者信息

Deng Nanjie, Hoyte Ashley, Mansour Yara E, Mohamed Mosaad S, Fuchs James R, Engelman Alan N, Kvaratskhelia Mamuka, Levy Ronald

机构信息

Center for Biophysics & Computational Biology/ICMS, Department of Chemistry, Temple University, Philadelphia, Pennsylvania, 19122.

Center for Retrovirus Research and College of Pharmacy, The Ohio State University, Columbus, Ohio, 43210.

出版信息

Protein Sci. 2016 Nov;25(11):1911-1917. doi: 10.1002/pro.2997. Epub 2016 Aug 17.

DOI:10.1002/pro.2997
PMID:27503276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5079246/
Abstract

Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) bind at the dimer interface of the IN catalytic core domain (CCD), and potently inhibit HIV-1 by promoting aberrant, higher-order IN multimerization. Little is known about the structural organization of the inhibitor-induced IN multimers and important questions regarding how ALLINIs promote aberrant IN multimerization remain to be answered. On the basis of physical chemistry principles and from our analysis of experimental information, we propose that inhibitor-induced multimerization is mediated by ALLINIs directly promoting inter-subunit interactions between the CCD dimer and a C-terminal domain (CTD) of another IN dimer. Guided by this hypothesis, we have built atomic models of inter-subunit interfaces in IN multimers by incorporating information from hydrogen-deuterium exchange (HDX) measurements to drive protein-protein docking. We have also developed a novel free energy simulation method to estimate the effects of ALLINI binding on the association of the CCD and CTD. Using this structural and thermodynamic modeling approach, we show that multimer inter-subunit interface models can account for several experimental observations about ALLINI-induced multimerization, including large differences in the potencies of various ALLINIs, the mechanisms of resistance mutations, and the crucial role of solvent exposed R-groups in the high potency of certain ALLINIs. Our study predicts that CTD residues Tyr226, Trp235 and Lys266 are involved in the aberrant multimer interfaces. The key finding of the study is that it suggests the possibility of ALLINIs facilitating inter-subunit interactions between an external CTD and the CCD-CCD dimer interface.

摘要

变构HIV-1整合酶(IN)抑制剂(ALLINI)结合于IN催化核心结构域(CCD)的二聚体界面,并通过促进异常的高阶IN多聚化来有效抑制HIV-1。关于抑制剂诱导的IN多聚体的结构组织知之甚少,关于ALLINI如何促进异常IN多聚化的重要问题仍有待解答。基于物理化学原理并通过对实验信息的分析,我们提出抑制剂诱导的多聚化是由ALLINI直接促进CCD二聚体与另一个IN二聚体的C末端结构域(CTD)之间的亚基间相互作用介导的。在这一假设的指导下,我们通过整合氢氘交换(HDX)测量信息以驱动蛋白质-蛋白质对接,构建了IN多聚体中亚基间界面的原子模型。我们还开发了一种新颖的自由能模拟方法来估计ALLINI结合对CCD和CTD缔合的影响。使用这种结构和热力学建模方法,我们表明多聚体亚基间界面模型可以解释关于ALLINI诱导的多聚化的几个实验观察结果,包括各种ALLINI效力的巨大差异、耐药突变的机制以及溶剂暴露的R基团在某些ALLINI高效力中的关键作用。我们的研究预测CTD残基Tyr226、Trp235和Lys266参与异常多聚体界面。该研究的关键发现是它表明了ALLINI促进外部CTD与CCD-CCD二聚体界面之间亚基间相互作用的可能性。

相似文献

1
Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.变构HIV-1整合酶抑制剂通过直接介导亚基间相互作用促进异常蛋白质多聚化:结构和热力学建模研究
Protein Sci. 2016 Nov;25(11):1911-1917. doi: 10.1002/pro.2997. Epub 2016 Aug 17.
2
A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.C末端片段在变构抑制剂诱导的HIV-1整合酶异常多聚化中起关键作用。
J Biol Chem. 2014 Sep 19;289(38):26430-26440. doi: 10.1074/jbc.M114.589572. Epub 2014 Aug 12.
3
The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.A128T 耐药突变揭示了异常蛋白多聚化是变构 HIV-1 整合酶抑制剂的主要作用机制。
J Biol Chem. 2013 May 31;288(22):15813-20. doi: 10.1074/jbc.M112.443390. Epub 2013 Apr 24.
4
The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function.导致 HIV-1 整合酶超寡聚化和功能丧失的药物诱导界面。
mBio. 2023 Feb 28;14(1):e0356022. doi: 10.1128/mbio.03560-22. Epub 2023 Feb 6.
5
Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.抑制剂诱导HIV整合酶聚集的结构基础
PLoS Biol. 2016 Dec 9;14(12):e1002584. doi: 10.1371/journal.pbio.1002584. eCollection 2016 Dec.
6
A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.通过催化核心结构域的晶体学片段筛选鉴定出的一类新型变构HIV-1整合酶抑制剂。
J Biol Chem. 2016 Nov 4;291(45):23569-23577. doi: 10.1074/jbc.M116.753384. Epub 2016 Sep 19.
7
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.优化基于喹啉的变构 HIV-1 整合酶抑制剂的多聚化性质。
Viruses. 2024 Jan 28;16(2):200. doi: 10.3390/v16020200.
8
The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.H171T耐药机制揭示了Nδ-质子化的组氨酸171对于变构抑制剂BI-D与HIV-1整合酶结合的重要性。
Retrovirology. 2014 Nov 25;11:100. doi: 10.1186/s12977-014-0100-1.
9
Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.LEDGF/p75结合位点抑制剂对HIV-1整合酶变构抑制机制的分子模拟研究
PLoS One. 2014 Mar 5;9(3):e90799. doi: 10.1371/journal.pone.0090799. eCollection 2014.
10
Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer.取代喹啉 ALLINIs 在 HIV-1 整合酶寡聚体中的优化结合。
J Biol Chem. 2021 Jan-Jun;296:100363. doi: 10.1016/j.jbc.2021.100363. Epub 2021 Feb 2.

引用本文的文献

1
Retrointegration2023-Papers from the 7th International Conference on Retroviral Integration.《逆转录病毒整合2023——第七届逆转录病毒整合国际会议论文集》
Viruses. 2025 Jun 23;17(7):879. doi: 10.3390/v17070879.
2
Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression.探索锌C295作为一种双重HIV-1整合酶抑制剂:从链转移到3'-加工抑制
Pharmaceuticals (Basel). 2024 Dec 29;18(1):30. doi: 10.3390/ph18010030.
3
Brief Histories of Retroviral Integration Research and Associated International Conferences.逆转录病毒整合研究及相关国际会议简史
Viruses. 2024 Apr 13;16(4):604. doi: 10.3390/v16040604.
4
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.优化基于喹啉的变构 HIV-1 整合酶抑制剂的多聚化性质。
Viruses. 2024 Jan 28;16(2):200. doi: 10.3390/v16020200.
5
Biological and Structural Analyses of New Potent Allosteric Inhibitors of HIV-1 Integrase.新型 HIV-1 整合酶强效变构抑制剂的生物学和结构分析。
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0046223. doi: 10.1128/aac.00462-23. Epub 2023 Jun 13.
6
The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function.导致 HIV-1 整合酶超寡聚化和功能丧失的药物诱导界面。
mBio. 2023 Feb 28;14(1):e0356022. doi: 10.1128/mbio.03560-22. Epub 2023 Feb 6.
7
Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors.变构整合酶抑制剂对 HIV-1 整合的影响及 LEDGF/p75 和 HDGFL2 宿主因子的作用。
Viruses. 2022 Aug 26;14(9):1883. doi: 10.3390/v14091883.
8
Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors.多取代喹啉类 HIV-1 整合酶别构抑制剂。
Viruses. 2022 Jul 2;14(7):1466. doi: 10.3390/v14071466.
9
Multimodal Functionalities of HIV-1 Integrase.HIV-1 整合酶的多模态功能。
Viruses. 2022 Apr 28;14(5):926. doi: 10.3390/v14050926.
10
Retroviral integrase: Structure, mechanism, and inhibition.逆转录酶整合酶:结构、机制与抑制。
Enzymes. 2021;50:249-300. doi: 10.1016/bs.enz.2021.06.007. Epub 2021 Aug 23.

本文引用的文献

1
The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.在HIV-1复制早期,变构HIV-1整合酶抑制剂BI/D与LEDGF/p75之间的竞争性相互作用对抑制剂效力产生不利影响。
ACS Chem Biol. 2016 May 20;11(5):1313-21. doi: 10.1021/acschembio.6b00167. Epub 2016 Mar 2.
2
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes.HADDOCK2.2 网页服务器:生物分子复合物的用户友好型综合建模
J Mol Biol. 2016 Feb 22;428(4):720-725. doi: 10.1016/j.jmb.2015.09.014. Epub 2015 Sep 26.
3
Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation.HIV-1核衣壳蛋白在未成熟、成熟及整合酶抑制的病毒颗粒中的分布与再分布:整合酶在成熟过程中的作用
J Virol. 2015 Oct;89(19):9765-80. doi: 10.1128/JVI.01522-15. Epub 2015 Jul 15.
4
HIV-1 integrase multimerization as a therapeutic target.HIV-1整合酶多聚化作为一种治疗靶点。
Curr Top Microbiol Immunol. 2015;389:93-119. doi: 10.1007/82_2015_439.
5
Retroviral Integrase Structure and DNA Recombination Mechanism.逆转录病毒整合酶结构与DNA重组机制
Microbiol Spectr. 2014;2(6):1-22. doi: 10.1128/microbiolspec.MDNA3-0024-2014..
6
The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.H171T耐药机制揭示了Nδ-质子化的组氨酸171对于变构抑制剂BI-D与HIV-1整合酶结合的重要性。
Retrovirology. 2014 Nov 25;11:100. doi: 10.1186/s12977-014-0100-1.
7
A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.C末端片段在变构抑制剂诱导的HIV-1整合酶异常多聚化中起关键作用。
J Biol Chem. 2014 Sep 19;289(38):26430-26440. doi: 10.1074/jbc.M114.589572. Epub 2014 Aug 12.
8
Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains.变构抑制人类免疫缺陷病毒整合酶:病毒复制过程中的晚期阻断和涉及特定蛋白结构域的异常多聚化。
J Biol Chem. 2014 Jul 25;289(30):20477-88. doi: 10.1074/jbc.M114.551119.
9
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.HIV-1非催化位点整合酶抑制剂(NCINI)BI 224436的发现。
ACS Med Chem Lett. 2014 Jan 22;5(4):422-7. doi: 10.1021/ml500002n. eCollection 2014 Apr 10.
10
A new class of multimerization selective inhibitors of HIV-1 integrase.一类新型的HIV-1整合酶多聚化选择性抑制剂。
PLoS Pathog. 2014 May 29;10(5):e1004171. doi: 10.1371/journal.ppat.1004171. eCollection 2014 May.